Visara appoints ophthalmology leaders to advance VIS-101 drug program

Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program
(NASDAQ: AURA) Delayed: 6.46 --0 (-0%)
Previous Close $6.46    52 Week High $ 
Open $6.46    52 Week Low $ 
Day High $6.46    P/E N/A 
Day Low $6.46    EPS $ 
Volume 24       

(NASDAQ: FDMT) Delayed: 12.59 --0 (-0%)
Previous Close $12.59    52 Week High $ 
Open $12.59    52 Week Low $ 
Day High $12.59    P/E N/A 
Day Low $12.59    EPS $ 
Volume 31       

(NASDAQ: NBP) Delayed: 1.37 --0 (-0%)
Previous Close $1.37    52 Week High $6.95 
Open $1.37    52 Week Low $6.95 
Day High $1.37    P/E 0.64 
Day Low $1.37    EPS $2.14 
Volume 708